There is evidence that the replication of RNA' viruses, and therefore that of viral RNA, is not mediated by DNA whereas most, if not all, of the RNA synthesis of the host cells is DNA-controlled.2 3 It thus appears that the synthesis of viral RNA may be catalyzed by an RNA-primed enzyme.2 Such an enzyme might be constitutive in the host cell or induced by infection with RNA viruses.
There is evidence that the replication of RNA' viruses, and therefore that of viral RNA, is not mediated by DNA whereas most, if not all, of the RNA synthesis of the host cells is DNA-controlled.2 3 It thus appears that the synthesis of viral RNA may be catalyzed by an RNA-primed enzyme.2 Such an enzyme might be constitutive in the host cell or induced by infection with RNA viruses.
Evidence will be presented in this paper that Escherichia coli cells infected with an RNA phage contain an RNA-synthesizing enzyme which is not present, or is present in negligible amounts, in noninfected cells. The enzyme, which is particulate in nature, catalyzes the incorporation of nucleotides from ribonucleoside triphosphates into RNA. It has been purified about 50-fold. Optimal nucleotide incorporation requires the presence of all four ribonucleoside 5'-triphosphates, i.e., ATP, GTP, UTP, and CTP. The enzyme preparations thus far obtained contain RNA and show no dependence on added RNA for activity. To distinguish this enzyme from the DNA-dependent RNA polymerase, it will be referred to as RNA synthetase.
Baltimore and Franklin4 have recently reported on the occurrence of a similar enzyme in L-cells infected with the RNA-containing Mengovirus.
M1aterials and Methods.-C'4-labeled ribonucleoside 5'-di-and triphosphates were obtained from Schwarz BioResearch, Inc., Orangeburg, N. Y. Nonlabeled ribonucleoside triphosphates were from Schwarz BioResearch, Inc. and the Pabst Laboratories, Milwaukee, Wisconsin. Calf thymus DNA, snake venom phosphodiesterase, and crystalline pancreatic RNAase and DNAase were obtained from the Worthington Biochemical Corporation, Freehold, New Jersey. Crystalline pyruvate kinase and phosphoenolpyruvate were from C. F Phosphoenolpyruvate and pyruvate kinase were used in the assay to avoid the formation of nucleoside 5'-diphosphates during incubation thus ensuring that any incorporation of nucleotides into RNA would not be due to the action of polynucleotide phosphorylase, an enzyme that catalyzes synthesis of polyribonucleotides from ribonucleoside 5'-diphosphates. That the bulk of the nucleotide incorporation observed could not be due to polynucleotide phosphorylase was further shown by the fact that 0.1 M orthophosphate, which would completely inhibit the synthetic activity of this enzyme, caused only 15-20 per cent inhibition of nucleotide incorporation by protoplast lysates of infected E. coli under the above assay conditions. This small inhibition may be due to precipitation of Mn++ by the phosphate. DNAase was present in the incubation mixture to destroy DNA and prevent the activity of RNA polymerase, RNA being a very poor primer of this enzyme.9 Use of GTP as the labeled nucleotide avoided incorporation of label through the action of the enzyme catalyzing the synthesis of polyadenylic acid from ATP10' 11 or through the enzyme catalyzing the addition of cytidylic and adenylic acid residues to partially degraded amino acid transfer RNA.1'2 13 After incubation for 10 min at 370, 0.05 ml of eight per cent, neutralized sodium pyrophosphate and 10 ml of ice cold six per cent trichloroacetic acid were added to each sample. If necessary, 0.05 ml of one per cent crystalline bovine serum albumin was added to obtain bulky precipitation with trichloroacetic acid. The precipitate was collected by centrifugation at 2°, washed twice with 10 ml of six per cent trichloroacetic acid, dissolved in 1 ml of 1.0 N NH4OH, plated, dried under an infrared lamp, and its radioactivity measured with use of a windowless Geiger-Muller counter.
Under the assay conditions, the rate of incorporation of GMP-C14 was linear up to 10 min and, with lysates of infected protoplasts, proportional to the amount of protein between 100 and 600 ;ig. after centrifugation for 10 min at 30,000 g a clear supernatant ("nuclear" fraction).
Data on the activity of the supernatant and "nuclear" fractions from noninfected and infected protoplasts, under the conditions of the standard assay, are shown in Table 1 . It may be seen that there was little or no activity in either fraction before infection with the RNA phage. After infection the supernatant and "nuclear" fractions had similar specific activity. However, the total amount of enzyme was larger in the former than in the latter for it contained 2-4 times more protein. It may also be seen from Table 1 (experiment 1) that, when the assay was conducted in the absence of DNAase and in the presence of added DNA, both fractions exhibited higher GMP-C14 incorporation activity both before and after infection. The additional nucleotide incorporation under these conditions reflects the activity of the DNA-primed RNA polymerase. It is apparent that the "nuclear" fraction contained more RNA polymerase, and of much higher specific activity, than the supernatant. Eighty per cent of the RNA synthetase activity of the 30,000 g supernatant from infected protoplasts could be sedimented by centrifugation for two hr at 105,000 g. This indicates that the activity was associated with large molecules or particles. The specific activity of the resuspended precipitate was only slightly lower than that of the original supernatant.
Purification: All operations were conducted at 0°-5°. Thirty liters of culture of infected protoplasts yielded 567 ml of 30,000 g supernatant with 2.07 gm of protein.
Step 1. Extraction: As described above.
Step 2. Step 4. Removal of inactive proteins by adsorption on calcium phosphate gel: The opalescent solution from the above step was adjusted at 00 to pH 8.2 by addition of 0.28 ml of 1.0 M Tris. To this solution was added 7.8 ml of Ca3(PO4)2 gel (32 mg Ca3(P04)2/ml) and, after mixing rapidly, the mixture was immediately centrifuged at 25,000 g for five minutes. The supernatant solution, 28 ml, contained 18 mg of protein. This solution was stored at -120 for several days.
Steps 5 and 6. Deoxycholate treatment: To a 10 ml aliquot of the solution from the previous step (6.4 mg of protein) was added 1 ml of ten per cent sodium deoxycholate. After 30 min the solution was centrifuged at 26,000 g in the No. 40 rotor of the Spinco preparative ultracentrifuge. To the supernatant was added at once 0.4 ml/ml of 0.2 M MgSO4; this addition was made dropwise with vigorous stirring. The copious precipitate was removed by centrifugation at 30,000 g for ten minutes and discarded. The supernatant, 15.0 ml, contained 0.7 mg of protein. Properties of Enzyme.-The enzyme was very unstable during the early purification steps and lost activity rapidly. As may be seen from Table 2 , the enzyme was still unstable at step 4 of purification; it lost 50 per cent of its activity on storage for four days at -120.
The enzyme remained particulate throughout the purification thus far achieved. At step 6 ( Table 2) , centrifugation of the MgSO4 supernatant for two hours at 105,000 g sedimented 80-100 per cent of the activity. The solution of this precipitate had about the same specific activity as the MgSO4 supernatant. Its light absorption ratio 280 mj;/260 mu was below 0.6, indicating the presence of considerable amounts of nucleic acid.
Most of the RNA polymerase originally present in the 30,000 g supernatant was removed on purification of the synthetase. Thus, in one experiment the specific activity of the 30,000 g supernatant was 0.05 in the standard assay and 0.6 when assayed in the absence of DNAase and in the presence of added DNA, the difference representing the activity of the DNA-primed RNA polymerase. The corresponding step 6 fraction (prepared without using DNAase in step 2) that had been stored for several days had a specific activity of 1.6 in the former and 1.8 in the latter assay. On the other hand, polynucleotide phosphorylase -as assayed through the incorporation of AMP from C14-labeled adenosine diphosphate--was purified to a greater extent than the synthetase. However, 0.2 M inorganic phosphate completely inhibited the phosphorylase activity of a step 4 preparation while the incorporation of GMP from GTP-C14, in the standard synthetase assay, was inhibited only 17 per cent. The phage-induced RNA synthetase is therefore clearly distinct from RNA polymerase and polynucleotide phosphorylase.
Contrary to the DNA-primed RNA polymerase, which is strongly inhibited by actinomycin D,9 16 the RNA synthetase activity was not affected. In one experiment the specific activity at step 2 (Table 2) was 0.17 whether in the absence or presence of 24 usg of actinomycin D/ml. Table 3 shows data on the incorporation of C14-labeled nucleotides from each of the four ribonucleoside triphosphates and the effect of the presence of the other three nonlabeled triphosphates thereon. It may be seen that the presence of all four nucleoside triphosphates markedly increased the incorporation of each nucleotide.
Nature of Product. -Nucleic acid was isolated after incubation of a sample under (Table 2 ) enzyme. The fraction had been kept frozen for several days and had lost some activity.
Conditions of standard assay.
t mismoles of labeled nucleotide incorporated/min/mg protein.
the conditions of the standard assay, except that the scale was larger (step 6 enzyme, 240 1Ag of protein; final volume, 8 ml) and that the nucleoside triphosphate mixture consisted of ATP-C14 (4 /mole, 2.9 X 106 cpm/,umole) with nonlabeled GTP, UTP, and CTP. After precipitation and washing three times with 0.4 N perchloric acid, the precipitate was suspended in 1.0 ml of water, brought into solution by addition of dilute ammonium hydroxide, and the pH adjusted to 7.2 with 0.02 M Tris-HCl buffer of the same pH. The total radioactivity of the solution was 8,750 cpm. The nucleic acid was extracted with phenol,'7 the aqueous phase made 0.1 M with respect to potassium chloride, and the nucleic acid precipitated by addition of two volumes of ethanol. After standing for two hours at 00, the precipitate was collected by centrifugation and dissolved in 0.02 M Tris HCl buffer, pH 8.8, to make 1.6 ml solution. The total absorbancy of the solution at wavelength 260 m~uwas 70 and its radioactivity 7,080 cpm. A 0.8 ml aliquot of the above solution (total absorbancy, 35; 3,540 cpm) was incubated at 370 with Tris HCl buffer, pH 8.8, 40 ,umoles; MgCl2, 40 ,imoles; and snake venom phosphodiesterase, 200 MAg, in a final volume of 1.6 ml. Samples (0.2 ml) were withdrawn at various time intervals, mixed with 1.8 ml of ice-cold 0.4 N perchloric acid and 0.01 ml of two per cent serum albumin, and centrifuged at 30,000 9 for ten minutes. The absorbancy of the supernatant fluid at 260 m/A was determined as a measure of the release of acid-soluble nucleotides; the release of radioactivity was determined by difference between the total radioactivity of the sample and that remaining in the perchloric acid precipitate. For radioactivity determination the precipitate was dissolved in 1.0 N ammonium hydroxide. The results, given in Table 4 , show that acid-soluble nucleotides and radioactivity, i.e., AMP-C14, were released at about the same rate. This indicates that the AMP-C14 incorporated was uniformly distributed throughout the nucleic acid chains and suggests de novo synthesis rather than addition of AMP residues to the end of preformed RNA chains.
Another sample of AMP-C14 nucleic acid containing 40,000 cpm (prepared with step 3 enzyme) was dissolved in 1.0 ml of 0.4 N potassium hydroxide and incubated for 12 hr at 370. Over 99 per cent of the radioactive material became acid-soluble under these conditions. The solution was neutralized with perchloric acid and the potassium perchlorate removed by centrifugation. An aliquot (19, cross-linked) column. The recovery of radioactivity was 15,000 cpm of which 12,000 cpm were in the pooled AMP fractions and 3,000 cpm in the adenosine fraction. These results identify the AMP-C_4-containing product as RNA and show once more that the AMP was incorporated predominantly in nonterminal positions. Discussion. -As already noted, the enzyme preparations contain considerable amounts of nucleic acid, presumably RNA. Attempts to remove this endogenous RNA without denaturing the enzyme have thus far been unsuccessful. Therefore, it has not been possible to demonstrate a dependence on added RNA for activity of the enzyme. Nevertheless, the results as a whole suggest that the enzyme may be concerned with the replication of phage RNA. While the RNA might be removed on further purification, the possibility that the enzyme might be a nucleoprotein with firmly bound primer RNA should be kept in mind. Since the viral RNA has a molecular weight of about 700,00014 a nucleoprotein containing this RNA could have a sedimentation coefficient in the 30 S range.
Since the enzyme is particulate it is of some interest that Nathans et al.19 observed the incorporation of histidine-C14 into particle-bound protein by a cell-free protein synthesizing system of E. coli with f2 coliphage RNA as messenger. As the viral coat protein contains no histidine and was released into the supernatant during amino acid incorporation by this system, it may be that the particle-bound protein may in part consist of the virus-induced RNA synthetase described in this paper.
Summary. -Infection of E. coli with an RNA phage induces the formation of an enzyme catalyzing the incorporation of nucleotides from ribonucleoside 5'-triphosphates into RNA. This enzyme was purified about 50-fold and appears to be particulate in nature. Optimal activity requires the presence of all four ribonucleoside triphosphates, ATP, GTP, UTP, and CTP. The purified preparations are essentially free of DNA-dependent RNA polymerase but contain polynucleotide phosphorylase. They also contain large amounts of RNA and a dependence on added RNA for activity of the enzyme has not been shown. The enzyme, for which the name RNA synthetase is suggested, may be involved in the replication of viral RNA. I Abbreviations: RNA and DNA, ribonucleic and deoxyribonucleic acid; ATP, GTP, UTP, and CTP, the ribonucleoside 5'-triphosphates of adenosine, guanosine, uridine, and cytidine; GMP, guanosine monophosphate; AMP, adenosine monophosphate; Tris, tris(hydroxymethyl)-aminomethane; RNAase, pancreatic ribonuclease; DNAase, pancreatic deoxyribonuclease. The experiments to be described in this paper are concerned with the role of histones in nuclear function and chromosome structure. They deal with RNA synthesis in isolated nuclei or in chromatin strands, with the effects of different histones on this and other biosynthetic processes, and with the enhancement of RNA synthesis in histone-depleted nuclei.
We have shown previously that the addition of histones to isolated nuclei, or to nuclear ribosomes, inhibits or represses a number of their biosynthetic activities.1-9 For example, one can observe a decrease in the rate of incorporation of C"4-labeled amino acids into protein'-' or of C'4-adenosine into RNA5 7-9 when isolated thymus nuclei are given a supplement of basic proteins such as histones, protamines or polylysine. The inhibition observed is due in part to the fact that added histones can inhibit nuclear ATP synthesis9 and in this way prevent the ATP-dependent "activation" of amino acids needed for protein synthesist 11 and also diminish the kinase activities and ATP "pool" required for RNA synthesis.12' 13, 6 Such indirect effects are not surprising, considering that histones are known to have a very broad spectrum of inhibitory actions due to their ability to form complexes with many
